Comparison of the herbal mouthwash containing Syzygium aromaticum and Commiphora molmol with protact on the chemotherapy-induced mucositis

Comparison of the herbal mouthwash containing Syzygium aromaticum and Commiphora molmol with protact on the improvement of first and Second grade of Chemotherapy-induced mucositis

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20090613002027N19

Enrollment

Registered

2020-02-08

Start date

2020-02-04

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer patients undergoing chemotherapy.

Interventions

Intervention 1: Intervention group: The mouthwash containing Syzygium aromaticum (5%) and Commiphora molmol (5%) 5 ml three times a day. Intervention 2: Control group: The protact mouthwash 5 ml three

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age =18 years of age Willing to provide written informed consent First and second grade of chemotherapy-induced mucositis

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Primary outcome measures included improvement or termination of mucositis. Timepoint: At the beginning of treatment (day 1) and then on days 3, 5, 7 and 10. Method of measurement: Mucositis severity based on Common Terminology Criteria for Adverse Events and World Health Organization Criteria.	—

Secondary

Measure	Time frame
Pain severity. Timepoint: Days 1, 3, 5, 7, 10. Method of measurement: Based on the pain severity according to Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEbrahim salehifar

Sari University of Medical Sciences

esalehifar@mazums.ac.ir+98 11 3354 3083

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026